Autism Therapeutics Company Overview

Autism Therapeutics (“AT”) is a biopharmaceutical company seeking to develop pharmaceutical therapies for the clear unmet medical needs of patients with Autism.  Autism Therapeutics is currently in the final stages of clinical development of a new drug treatment for a core symptom of autism (repetitive behavior). AT001 has the potential to the be first drug ever to be FDA approved to modif a core symptom of autism. Autism Therapeutics is a pioneer in clinical trial design strategies aimed at addressing the complexity of heterogeneity in autism and is positioned to become one of the world’s leading drug development platforms for autism.